"EXCLUSIVE: Key Legal And Tax Ramifications Of Federal Cannabis Rescheduling, Insights From Dykema Gossett PLLC"

Lance Boldrey was quoted extensively in the Benzinga article, "EXCLUSIVE: Key Legal And Tax Ramifications Of Federal Cannabis Rescheduling, Insights From Dykema Gossett PLLC." In the article, Boldrey analyzes the potential impact of reclassifying cannabis to Schedule III under the Controlled Substance Act.